In recent years, the in vitro diagnostics (IVD) market has developed rapidly both domestically and internationally, especially driven by the pandemic, and the IVD industry in foreign countries has flourished. However, compared with the booming development of foreign markets, domestic

enterprises are facing many challenges and appear to be struggling. Desheng will discuss in detail why domestic IVD raw material enterprises are facing such difficulties on this issue.

 

IVD raw material

 

The IVD raw material market is fiercely competitive with high technological barriers

 

1. Strong competitors: The foreign IVD market has long been monopolized by some giants, who have strong research and development capabilities and advanced production processes, and can continuously launch high-quality and high-performance products. In contrast, there is still a significant gap in brand awareness, technological level, and market share among domestic IVD raw material enterprises.

 

2. High technical barriers: The research and production of IVD raw materials involve complex technologies and processes. For example, the production of key raw materials such as fluorescent probes, nucleic acid amplification enzymes, and antibodies requires high-level technology and strict quality control. These technological barriers make it difficult for many domestic enterprises to quickly break through, thereby affecting their market competitiveness.

 

Insufficient R&D investment and limited innovation capability

 

1. Financial issue: Many domestic IVD raw material enterprises are relatively small in scale and lack sufficient financial support. Insufficient R&D investment makes it difficult for enterprises to engage in long-term technological innovation and product development, thus placing them at a disadvantage in market competition.

 

2. Talent shortage: The research and development of IVD raw materials requires high-quality scientific research talents. However, there is a shortage of talent reserves in relevant fields in China, and technical talents tend to choose to enter foreign-funded enterprises or develop abroad, leading to difficulties for domestic enterprises in terms of talent.

 

Incomplete industrial chain and unstable supply chain

 

1. Upstream raw materials rely on imports: Many key IVD raw materials, such as high-purity biochemical reagents and high-quality antibodies, have not yet fully matured in domestic production technology, and some customers still rely on imports. This not only increases the cost for enterprises, but also poses significant uncertainty to the supply chain.

 

2. Incomplete supporting facilities: The production of IVD raw materials requires advanced production equipment and a strict quality control system. The supporting facilities in China are not yet perfect, and many enterprises face problems such as insufficient equipment and difficult quality control in the production process, which further restricts their development.

 

Unclear enterprise management and strategic positioning

 

1. Management level urgently needs to be improved: Many domestic IVD raw material enterprises have shortcomings in management, such as a lack of scientific management systems and operational models. This leads to slow reactions of enterprises in the face of market changes and technological progress, making it difficult to quickly adapt to market demand.

 

2. Unclear strategic positioning: Some enterprises do not have a clear strategic positioning in their development process, their product lines are scattered, and they lack core competitiveness, which makes it difficult for them to establish advantages in market competition and achieve sustainable development.

 

Desheng's coping strategies

 

As one of the representative enterprises in the domestic IVD raw material industry, Desheng has actively taken a series of response measures in the face of the above challenges, mainly focusing on the following aspects:

 

1. Increase R&D investment: Desheng realizes the importance of technological innovation and has significantly increased R&D investment in recent years, with dedicated R&D centers that attract technical talents to join. At the same time, the company actively cooperates with universities, conducts cutting-edge technology research, and continuously improves the technical level and quality of its products.

 

2. Optimizing the layout of the industrial chain: In order to solve the problem of upstream raw material dependence on imports, Desheng actively lays out the upstream industrial chain, increases independent research and development of key raw materials, and builds production capacity. In addition, the company strengthens cooperation with customers, establishes a stable supply chain system, and ensures the continuity and stability of production.

 

3. Strengthening management and brand building: Desheng continuously optimizes enterprise management, establishes a scientific management system and operation mode, and improves the management level and market response speed of the enterprise. At the same time, the company actively carries out brand building, improving brand awareness and market influence by participating in domestic and foreign exhibitions, strengthening market promotion, and other means.

 

4. Seeking policy support: Desheng actively communicates with departments and strives for policy support. The company has participated in the formulation of multiple industry standards, promoting the standardized development of the industry. At the same time, actively apply for various technological projects and financial support, providing strong policy guarantees for the development of enterprises.

 

Desheng's laboratory

 

Although domestic IVD raw material enterprises face many challenges in their development process, as long as they can recognize the situation and actively respond, they are expected to stand out in the fierce market competition. As a representative of the industry, Desheng has gradually overcome development difficulties through a series of measures such as increasing research and development investment, optimizing industrial chain layout, strengthening management and brand building. I believe that with the continuous development of the industry and the continuous optimization of the policy environment, domestic IVD raw material enterprises will surely usher in their own dawn.

 

Desheng supplies a series of in vitro diagnostic reagent raw materials, such as blood collection additives, biological buffering agents, luminescent reagents, and other products, which can meet the diversified needs of the market. If you are interested in this aspect, you can also click on the website to consult us at any time!